´ëÇѳ»ºÐºñÇÐȸ Ãá°èÇмú´ëȸ ¹× Çп¬»ê ½ÉÆ÷Áö¾ö : 2021-04-10±³À°ÀÏÀÚ : 2021-04-10
±³À°Àå¼Ò : ¿©¼ö¿¢½ºÆ÷ÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ :
´ëÇѳ»ºÐºñÇÐȸ Ãá°èÇмú´ëȸ ¹× Çп¬»ê ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : ´ëÇѳ»ºÐºñÇÐȸ
¿¬¶ôó : 02-2038-0072
À̸ÞÀÏ :
endo@endocrinology.or.kr ±³À°Á¾·ù : ³»°ú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
Àü¶ó³²µµ±³À°½Ã°£ : 11 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í (Æò»ýȸ¿ø, Á¤È¸¿ø) Àü¹®ÀÇ / ÀüÀÓÀÇ / ±³¼ö / °³¿øÀÇ / ±âÃÊÀÇÇÐÀÚ: 100,000¿ø Àü°øÀÇ / ´ëÇпø»ý / ±ºÀÇ°ü / °øÁߺ¸°ÇÀÇ/ °£È£»ç / ¿µ¾ç»ç / ÀÇ·á±â»ç / ±âŸ: 50,000¿ø (ºñȸ¿ø) Àü¹®ÀÇ / ÀüÀÓÀÇ / ±³¼ö / °³¿øÀÇ / ±âÃÊÀÇÇÐÀÚ: 150,000 Àü°øÀÇ / ´ëÇпø»ý / ±ºÀÇ°ü / °øÁߺ¸°ÇÀÇ/ °£È£»ç / ¿µ¾ç»ç / ÀÇ·á±â»ç / ±âŸ: 70,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 1 (Live Channel 2) 09:00~09:25 ÀÇ·á ±¤À½Çâ ¿µ»óÀÇ ¿ø¸®¿Í °©»ó¼± ¾Ï ¿µ»ó ÆÄÀÏ·µ ¿¬±¸ °á°ú ±èöȫ(Æ÷Ç×°ø´ë âÀÇITÀ¶ÇÕ°øÇаú)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 1 (Live Channel 2) 09:25~09:50 CXCL16, a regulator of tumor microenvironment in advanced thyroid cancer Á¶¼±¿í(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 1 (Live Channel 2) 09:50~10:15 ÀΰøÁö´ÉÀ» ÀÌ¿ëÇÑ °©»ó¼±°áÀý Áø´ÜÀÇ ¹Ì·¡ ¹éÁ¤È¯(¿ï»êÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 1 (Live Channel 2) 13:30~13:50 How dose COVID-19 affect osteoporosis and fracture? ÇÏ¿ëÂù(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 1 (Live Channel 2) 13:50~14:10 Acute sarcopenia secondary to COVID-19 ±è¹üÁØ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 1 (Live Channel 2) 14:10~14:30 Can vitamin D protect against COVID-19? ÃÖÇѼ®(µ¿±¹ÀÇ´ë)
Åä·Ð 04¿ù 10ÀÏ ±×·£µåȦ 1 (Live Channel 2) 14:30~15:00 Panel Discussion ±è°æ¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 2 (Live Channel 3) 09:00~09:20 Disease of a thousand faces: Hyperparathyroidism ÀÌÀ¯¹Ì(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 2 (Live Channel 3) 09:20~09:40 Is vitamin D supplementation safe and effective? Steady low dose vs intermittent high dose °ø¼ºÇý(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 2 (Live Channel 3) 09:40~10:00 Clinical effectiveness of romosozumab and teriparatide ±èÇÏ¿µ(¿ï»êÀÇ´ë)
Åä·Ð 04¿ù 10ÀÏ ±×·£µåȦ 2 (Live Channel 3) 10:00~10:30 Panel Discussion ±è»ó¿Ï(¿Â¶óÀÎ Âü¿©)(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 2 (Live Channel 3) 13:30~13:50 ´ëÇѺñ¸¸ÇÐȸ ºñ¸¸ Áø·á Áöħ ³²°¡Àº(°í·ÁÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 2 (Live Channel 3) 13:50~14:10 ºñ¸¸Ä¡·áÀÇ ÃÖ½ÅÁö°ß ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ±×·£µåȦ 2 (Live Channel 3) 14:10~14:30 Saxenda (Liraglutide 3.0 mg) real world study of Korea ÀÓ¼ö(¼¿ïÀÇ´ë)
Åä·Ð 04¿ù 10ÀÏ ±×·£µåȦ 2 (Live Channel 3) 14:30~15:00 Panel Discussion °ÁöÇö(°Ç¾çÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 04¿ù 10ÀÏ ¼¼¹Ì³ª½Ç 4 09:00~09:20 Epidemiology of acromegaly in Korea: Based on big data analysis ¹Ú°æÇý(±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø)
±³À°½Ã°£ 04¿ù 10ÀÏ ¼¼¹Ì³ª½Ç 4 09:20~09:40 Autoimmune pituitary diseases Yutaka Takahashi(Nara Medical University, Japan)
±³À°½Ã°£ 04¿ù 10ÀÏ ¼¼¹Ì³ª½Ç 4 09:40~10:00 Co-peptin: A new pituitary hormone? ±èÁ¤Èñ(¼¿ïÀÇ´ë)
Åä·Ð 04¿ù 10ÀÏ ¼¼¹Ì³ª½Ç 4 10:00~10:30 Panel Discussion ±¸Ã¶·æ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 09:00~09:20 LDL: PCSK9 inhibitor as the next statin? ÀÌ»óÇÐ(¿¬¼¼ÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 09:20~09:40 TG: Is hypertriglyceridemia atherogenic? ±è³²ÈÆ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 09:40~10:00 Does HDL-cholesterol paradox exist? À̽Âȯ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 10:00~10:20 Lp(a): Lipoprotein(a) and CV risk : Are we there yet? ±è»óÇö(¼¿ïÀÇ´ë ½ÉÀå³»°ú)
Åä·Ð 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 10:20~10:30 Panel Discussion ±è»ó¼ö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 10:50~11:20 Cellular senescence : Future translational viewpoint °¹«ÀÏ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 11:20~11:50 Olfactory Receptors & Olfactory Marker Protein signals in endocrine system ÀÌÀºÁ÷(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 12:40~13:20 Precision medicine in diabetes ¹Ú°æ¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 13:30~13:50 Epidemiology of adrenal cushing ¾Èâȣ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 13:50~14:10 CT-based body composition biomarkers in hypercortisolism È«³²±â(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 14:10~14:30 Introduction to new medical drugs for adrenal diseases ¹ÚÁ¤È¯(ÇѾçÀÇ´ë)
Åä·Ð 04¿ù 10ÀÏ ¿¢½ºÆ÷Ȧ (Live Channel 1) 14:30~15:00 Panel Discussion ±¸À¯Á¤(ÃæºÏÀÇ´ë)